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Santiago P. Mendez-Huergo5, Tomas Dalotto-Moreno5, Alexandre Wojcinski6, Francisca Ochoa2, Shemin Zeng7, Juan P. Cerliani5, Lampros Panagis2,
Patrick J. Zager1, Robert F. Mullins7, Shuntaro Ogura8, Gerard A. Lutty8, Jakyung Bang9, Jonathan H. Zippin9, Carmelo Romano2,
Gabriel A. Rabinovich5,10, Olivier Elemento3, Alexandra L. Joyner6, Shahin Rafii11, Enrique Rodriguez-Boulan1, and Ignacio Benedicto1,12
The activity and survival of retinal photoreceptors depend on support functions performed by the retinal pigment epithelium
(RPE) and on oxygen and nutrients delivered by blood vessels in the underlying choroid. By combining single-cell and bulk RNA
sequencing, we categorized mouse RPE/choroid cell types and characterized the tissue-specific transcriptomic features of
choroidal endothelial cells. We found that choroidal endothelium adjacent to the RPE expresses high levels of Indian
Hedgehog and identified its downstream target as stromal GLI1+ mesenchymal stem cell–like cells. In vivo genetic impairment
of Hedgehog signaling induced significant loss of choroidal mast cells, as well as an altered inflammatory response and
exacerbated visual function defects after retinal damage. Our studies reveal the cellular and molecular landscape of adult
RPE/choroid and uncover a Hedgehog-regulated choroidal immunomodulatory signaling circuit. These results open new
avenues for the study and treatment of retinal vascular diseases and choroid-related inflammatory blinding disorders.
Introduction
Photoreceptors capture incoming photons and transform them
into electrical pulses that ultimately lead to visual perception.
Their localization to the outer retina, distal to the incoming light
and visual processing neurons of the inner retina, is a successful
evolutionary design that allows vertebrate photoreceptors to
benefit from the critical support of two external eye layers, the
retinal pigment epithelium (RPE) and the choroidal blood ves-
sels. The RPE enables photoreceptor function by eliminating
stray light, phagocytosing photoreceptor waste products neces-
sary for their renewal, recycling visual cycle components, and
constituting an essential component of the outer blood–retinal
barrier between choroidal circulation and the neural retina
(Strauss, 2005). Whereas separate retinal blood vessels nourish
the inner retina, blood supplied by the choroidal circulation is
the main source of oxygen and nutrients for RPE and photo-
receptors and the main evacuation route for retinal waste
(Nickla and Wallman, 2010). Thus, choroidal perfusion is es-
sential for RPE and retinal homeostasis. However, this is likely
not the only role of choroidal endothelial cells (ECs), as recent
studies have shown that microvascular ECs are not passive
conduits for delivering blood but rather organ-specific factories
of highly specialized sets of angiocrine factors that regulate
tissue homeostasis and regeneration (Rafii et al., 2016). Recently,
we provided initial evidence for this scenario in the eye. We
reported that developing and adult mouse choroidal ECs exhibit
different transcriptomes, and such transition is likely required
for the coordinated establishment of the outer blood–retinal
barrier and the acquisition of visual function (Benedicto et al.,
2017). However, specific transcriptome features of choroidal ECs
compared with retinal and extraocular ECs and the molecular
identities of nonendothelial choroidal cell types have not been
determined in detail so far. RPE and choroid act as a functional
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unit, and defects in any of their supportive roles can cause
retinal degeneration and blinding diseases such as age-related
macular degeneration (AMD). AMD, an incurable disease that
affects 8.7% of the worldwide population and 25% people >80 yr
old, is characterized by photoreceptor loss secondary to dys-
function or death of the RPE and choroidal ECs (Ambati and
Fowler, 2012; Mullins et al., 2011; Seddon et al., 2016; Wong
et al., 2014). The etiology of AMD remains largely unknown,
in part due to the very limited availability of molecular infor-
mation about the different cell types that populate the choroid
and the intercellular networks that maintain RPE/choroid tissue
in a healthy and functional state.
Single-cell RNA sequencing (scRNAseq) is a recently devel-
oped approach that allows efficient transcriptional profiling of
individual cells in a given tissue or other complex cellular
populations (Macosko et al., 2015). This technology has opened
the door to answering longstanding biological questions on tis-
sue cell diversity, heterogeneity of cellular responses, and reg-
ulatory signaling networks that would be difficult or impossible
to answer using traditional physiological or biochemical ap-
proaches. A recent landmark study characterized by scRNAseq
the molecular identity of all cell types in the mouse neural retina
but did not analyze RPE or choroid (Macosko et al., 2015). More
recently, scRNAseq was used to create a mouse cell atlas cov-
ering all major organs, but RPE and choroid were not included
(Han et al., 2018). Here, we report a scRNAseq analysis of adult
mouse RPE/choroid and provide the transcriptional signature of
choroidal ECs compared with other tissue-specific ECs, includ-
ing retinal ECs. Our studies uncover the molecular identity of
the major choroidal cell types, including three different EC
subtypes and a previously uncharacterized population of me-
senchymal stem cell (MSC)–like cells. Moreover, MSC-like cells
are the target of EC-secreted Indian Hedgehog (IHH), which was
found to be a critical modulator of choroidal and retinal in-
flammatory responses. These results open new avenues for the
study and treatment of retinal vascular diseases and choroid-
related inflammatory blinding disorders such as AMD.
Results
Characterization of mouse RPE/choroid by scRNAseq
Transcriptional profiling at single-cell resolution requires high-
quality cell suspensions. To this end, we developed a fast and
efficient procedure to isolate single cells from RPE/choroid by
sequential tissue digestion and cell sorting. We used FACS to
optimize the capture of single, viable cells (TO-PRO-3 negative)
and separate nucleated cells (Hoechst positive) from cell debris
(Figs. 1 a and Fig. S1 a). We surgically dissected RPE/choroid
tissue from eyes enucleated from 90-d-old mice of two different
strains, C57BL/6J and B6129PF1/J, and sequenced 3,996 and 3,727
cells from each strain, respectively. To avoid any potential sex-
related bias during our analyses, we pooled tissue from two eyes,
one male and one female, for each strain during enzymatic di-
gestion. In addition, this approach allowed us to estimate that
∼4% of isolated cells were present as doublets (i.e., two cells
barcodedwith the same sequence), based on the assumption that
male–female doublets accounted for 50% of total doublets (Fig.
S1 b; Macosko et al., 2015). Unsupervised clustering of individual
cell transcriptomes based on similarity in overall gene expres-
sion identified 13 transcriptionally distinct clusters within RPE/
choroid cells (Fig. 1 b), with remarkably similar results for both
strains (Fig. S1 c). Using the FindConservedMarkers function in
Seurat, we found ≥65 conserved cluster-specific genes for each
cluster in both mouse strains (adjusted [adj] P < 0.05; Data S1 a).
Based on these gene lists and the expression of known cell-
type–specific markers, we categorized these clusters as RPE,
ECs, stromal cells, smooth muscle cells, melanocytes, hemato-
poietic cells, and Schwann cells (Fig. 1 c, B6129PF1/J strain; Fig.
S1 d, C57BL/6J strain; and Table 1). This analysis identified
subtypes within ECs (clusters 2–4), stromal cells (clusters 5–8),
and Schwann cells (clusters 12 and 13). The complete datasets for
both strains are reported in Data S1 (b and c).
Identification of transcriptionally distinct choroidal
EC subtypes
The choroidal vasculature plays key roles in retinal homeostasis
and in the pathogenesis of blinding diseases such as AMD
(Bhutto and Lutty, 2012; Nickla and Wallman, 2010; Whitmore
et al., 2015); hence, we were particularly interested in further
characterizing choroidal EC subtypes. EC clusters 2–4 presented
similar expression levels of the generic EC markers Cdh5 (VE-
cadherin), Pecam1 (CD31), Flt1 (VEGFR1), and Cldn5 (claudin-5);
however, they displayed remarkable variations in the expres-
sion of other markers. Because Kdr (VEGFR2) was expressed at
decreasing levels in EC clusters 2–4 (Fig. 1 c and Fig. S1 d), we
termed these clusters Kdrhigh, Kdrmed, and Kdrlow ECs, respec-
tively. To study the most significant transcriptional differences
between Kdrhigh and Kdrlow ECs, we selected the genes whose
expression in Kdr high was detected by an average of ≥1 normal-
ized unique molecular identifier (UMI), and the average number
of normalized UMIs was at least fivefold higher than in Kdrlow
ECs and vice versa. Average normalized UMIs for each gene in
Kdrmed were also included in the analysis for comparison pur-
poses (Data S1, d and e). Using this filtering approach, we found
19 genes specifically enriched in Kdrhigh compared with Kdrlow
(Fig. 1 d, top panel) and 19 genes with the opposite expression
pattern (Fig. 1 d, bottom panel). In general, gene expression in
Kdrmed was intermediate between Kdrhigh and Kdrlow, suggesting
that Kdrmed constitutes a transitional EC population between the
other two.
The choriocapillaris is the capillary network immediately
adjacent to the RPE basement membrane that provides nutrition
and a waste evacuation route to the outer retina, and it is
characterized histologically by the presence of fenestrations in
the EC plasma membrane (Lutty et al., 2010; Nickla and
Wallman, 2010). As the gene with highest expression in Kdrhigh
ECs is Plvap (Fig. 1 d, top panel), which encodes the fenestrae-
associated protein PV1 (Stan et al., 2012), it is likely that the
Kdrhigh cluster represents choriocapillaris ECs, whereas the
Kdrlow cluster corresponds to ECs from deeper choroid capillar-
ies. To test this hypothesis, we performed immunofluorescence
experiments using antibodies against KDR and RPE65, an RPE
marker. KDR was detected in the innermost choroidal layer very
close to the RPE (Fig. 1 e, left), consistent with the location of the
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Figure 1. Characterization of mouse RPE/choroid by scRNAseq and identification of transcriptionally distinct choroidal EC subtypes. (a) Scheme of
the preparation of RPE/choroid single-cell suspensions by sequential enzymatic digestion and cell sorting. Hoechst+/TO-PRO-3− live cells were subjected to
scRNAseq. (b) Principal-component analysis of 7,723 single-cell expression profiles obtained from RPE/choroid tissue from four mice (C57BL/6J and B6129PF1/J
strains, one male and one female per strain). Data are shown in two dimensions using tSNE. Unsupervised analysis clustered cells into 13 transcriptionally
distinct cell populations, each plotted in a different color. (c) Identification of cell types in RPE/choroid tissue from B6129PF1/J mice according to the average
expression of known markers in each cluster. Cluster number colors are the same as in panel b. Relative gene expression among cell types was calculated using
the average normalized UMIs in each cluster and represented as the percentage of the cluster with maximum expression. White, 0%; red, 100%. (d) Genes with
at least fivefold differential expression between Kdrhigh (green bars) and Kdrlow (purple bars) ECs (Benjamini–Hochberg adjusted likelihood-ratio test, adj P <
0.05). Only genes with maximum average normalized UMIs ≥1 are shown. Relative gene expression in Kdrmed ECs (brown bars) is also included. Top: Kdrhigh
expression at least fivefold higher than Kdrlow. Bottom, Kdrlow expression at least fivefold higher than Kdrhigh. (e) Immunofluorescence analysis of KDR (red),
RPE65 (RPE marker), and claudin-5 (pan-endothelial marker; green) expression in mouse eye cryosections. Nuclear staining with DAPI (blue) and differential
interference contrast images are also included in merged panels. Position of RPE and choroid (Ch) is indicated on the left of merged images. Scale bars, 5 µm
(left) and 10 µm (right). Images are representative of four mice.
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choriocapillaris. We also costained KDR and claudin-5, a pan-
endothelial marker expressed at similar levels in Kdrhigh, Kdrmed,
and Kdrlow choroidal ECs (Fig. 1 c and Fig. S1 d). Claudin-5 ex-
pression was found both in KDR+ ECs and in deeper choroidal
layers closer to the sclera with undetectable KDR expression
(Fig. 1 e, right), the latter likely corresponding to Kdrlow ECs.
These experiments strongly suggest that Kdrhigh and Kdrlow
clusters correspond to transcriptionally and geographically dis-
tinct populations of choroidal ECs.
Tissue-specific enrichment of Ihh expression in choriocapillaris
ECs
It is becoming evident that adult ECs have tissue-specific tran-
scriptomes reflecting context-dependent physiological and re-
generative roles (Rafii et al., 2016). We recently reported the
transcriptome of developing and adult mouse choroidal ECs,
isolated by intravital staining of the EC marker VE-cadherin,
followed by RPE/choroid digestion, flow cytometry sorting, and
bulk RNA sequencing (RNAseq; Benedicto et al., 2017). Here, we
followed the same approach to compare the transcriptional
profile of ECs from adult mouse choroid, neural retina, lung,
heart, and liver (Fig. 2 a). Hierarchical clustering analysis
demonstrated marked transcriptome differences between the
various EC types (Fig. 2 b). We identified a list of 99 “signature
genes” of mouse choroidal ECs that were expressed at levels at
least fivefold higher than in the other ECs, with a detection
threshold set at ≥1 fragments per kilobase per million reads
(FPKMs; Data S1 f). By comparing our bulk and single cell
RNAseq data, we were able to determine the relative expression
of every choroidal EC signature gene relative to other RPE/
choroid cell types. Out of 99 genes, 21 were specifically enriched
in choroidal ECs (Fig. 2 c; >50% of the sum of average normalized
UMIs from all RPE/choroid cell types), from which 16 were
significantly more abundant (adj P < 0.05) in Kdrhigh (chorio-
capillaris) ECs than in Kdrmed and Kdrlow choroidal ECs (Data S1, d
and g). Our studies provide the first comprehensive list of spe-
cific molecular markers for all choroidal ECs relative to not only
other choroidal cell types but also other tissue-specific ECs. They
demonstrate that the choriocapillaris is the most specialized
vascular subtype within the choroid and provide an important
platform for future studies on choroid physiopathology and the
pathogenesis of choroid-based blinding diseases.
One of the genes specifically enriched in Kdrhigh (choriocap-
illaris) ECs was Ihh (Fig. 2 c). The three secreted Hedgehog (HH)
proteins (IHH, Sonic Hedgehog, and Desert Hedgehog) act in a
paracrine manner, and in most tissues are expressed by epi-
thelial cells and signal to the surrounding mesenchyme (Petrova
and Joyner, 2014; Wu et al., 2017). Detailed examination of our
bulk RNAseq data revealed that Ihh expression in choroidal ECs
was >340-fold higher than in the rest of the tissue-specific ECs
(Fig. 2 d), an observation that was confirmed by real-time PCR
assays (Fig. 2 e). Expression of the generic EC markers Cdh5,
Pecam1, and Kdr was similar among all tissue-specific ECs, fur-
ther highlighting the specificity of Ihh enrichment (Fig. 2 d).
Importantly, IHH expression in human RPE/choroid tissue from
healthy donors was markedly higher than in neural retina, lung,
liver, and heart, as assessed by real-time PCR (Fig. 2 f). Our
observation that Ihh is expressed at high levels in adult chorio-
capillaris is particularly intriguing, as IHH is known to regulate
prenatal mouse eye development (Dakubo et al., 2008).
Table 1. Mouse RPE/choroid cell types identified by scRNAseq
Cluster
number





















1 RPE 402 445 10.1 11.9 4,860 7,514 1,468 1,911 3.02 3.51
2 ECs 405 366 10.1 9.8 4,550 5,151 1,920 2,090 2.18 2.32
3 ECs 550 435 13.8 11.7 4,847 5,570 1,943 2,139 2.28 2.42
4 ECs 74 63 1.9 1.7 4,749 5,196 1,894 2,025 2.26 2.37
5 Stromal cells 776 797 19.4 21.4 3,255 3,723 1,524 1,645 2.09 2.21
6 Stromal cells 610 552 15.3 14.8 3,171 3,796 1,491 1,681 2.07 2.21
7 Stromal cells 223 229 5.6 6.1 3,695 4,518 1,684 1,894 2.14 2.32
8 Stromal cells 158 166 4.0 4.5 2,995 3,944 1,391 1,661 2.13 2.33
9 Smooth muscle
cells
476 400 11.9 10.7 3,863 4,769 1,583 1,814 2.38 2.58
10 Melanocytes 28 20 0.7 0.5 3,913 5,008 1,621 1,847 2.32 2.59
11 Hematopoietic
cells
140 116 3.5 3.1 4,573 4,960 1,528 1,496 2.83 3.19
12 Schwann cells 108 106 2.7 2.8 2,525 2,835 1,306 1,418 1.90 1.96
13 Schwann cells 46 32 1.2 0.9 2,606 3,532 1,227 1,495 2.08 2.31
Total 3,996 3,727
Data are from C57BL/6J and B6129PF1/J mice (pooled cells from one male and one female for each strain).
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Figure 2. Transcriptional analysis of tissue-specific mouse ECs and Ihh expression in choriocapillaris ECs. (a) Diagram showing the isolation of tissue-
specific ECs after intravital EC labeling. For RPE/choroid and neural retina, seven animals (14 eyes) were used per isolation; for lung, liver, and heart, one animal
was used per isolation. Bulk RNAseq was performed using RNA from three independent isolations. (b) Hierarchical clustering of FPKM profiles showing
separate clustering of tissue-specific ECs (n = 3). (c) Signature genes of mouse choroidal ECs and relative expression among RPE/choroid cell types. Using data
from the bulk RNAseq analyses of tissue-specific ECs, the list was assembled by selecting the genes with expression levels at least fivefold higher in choroidal
ECs compared with the rest of the tissue-specific ECs (n = 3, Benjamini–Hochberg corrected adj P < 0.05), with a detection threshold set at ≥1 FPKM. The list
was then interrogated against our scRNAseq data to assess the relative expression of each gene among all cell types, which was calculated using the average
normalized UMIs in each cluster and represented as the percentage of the cluster with maximum expression. White, 0%; red, 100%. The column labeled “CC
expression” shows the average normalized UMIs (log10) for each gene in Kdrhigh ECs, i.e., the choriocapillaris (CC), represented in a white-purple scale. Black-
gray bars on the right represent EC specificity compared with the rest of RPE/choroid cell types. For each gene, the sum of the average normalized UMIs in
Kdrhigh, Kdrmed, and Kdrlow ECs was represented as the percentage of total average normalized UMIs (the sum of average normalized UMIs in all clusters). The
black portion of the bars represents the percentage of estimated EC specificity. Only genes with >50% EC specificity are shown. (d) Bulk RNAseq results
showing the expression (FPKM) of Ihh (red) and the EC markers Cdh5 (black), Pecam1 (gray), and Kdr (blue) in tissue-specific ECs (n = 3). ***, Benjamini–
Hochberg corrected adj P < 0.001 all groups versus choroidal ECs. (e) Real-time PCR showing relative Ihh expression in tissue-specific ECs. Results are
presented as the percentage of the average value for choroidal ECs (n = 3, ANOVA + Bonferroni test). ***, P < 0.001 all groups versus choroidal ECs. nd, not
detected. (f) Real-time PCR showing relative IHH expression in human whole tissues (RPE/choroid, n = 4; neural retina, n = 5; commercially obtained lung, liver,
and heart, n = 1). Biological replicates are shown as black dots. Red lines show the average expression in RPE/choroid and neural retina. Results are presented
as the percentage of the average value for RPE/choroid tissue.
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However, its expression and potential role in the adult mouse
eye has never been studied before. These results prompted us
to study the signaling pathway downstream of choroidal EC-
expressed Ihh.
Localization and characterization of choroidal GLI1+ IHH target
cells
Because IHH is a secreted protein expected to signal to the
surrounding mesenchymal cells, we sought to identify cell types
within RPE/choroid capable of responding to EC-expressed Ihh.
Visualization of Ihh-expressing cells on t-distributed stochastic
neighbor embedding (tSNE) plots confirmed that Ihh transcripts
are constitutively enriched in the Kdrhigh subcluster of ECs, while
the expression of the gene encoding the transcriptional activator
GLI1, a transcriptional target dependent on HH signaling and
thus a readout of canonical HH pathway activity (Ahn and
Joyner, 2005; Bai et al., 2004; Petrova and Joyner, 2014; Wu
et al., 2017), was specifically increased in stromal cell clusters
5–8 relative to other choroidal cell types (Fig. 3 a). More detailed
analysis of our scRNAseq data confirmed the stromal specificity
of Gli1 expression (Fig. 3 b). Although the Ptch1 gene encoding the
HH receptor presented a broader expression pattern than Gli1, it
was clearly enriched in stromal cells (Fig. 3 b). This is consistent
with the fact that Ptch1, in addition to encoding the HH receptor,
is up-regulated in response to HH signaling (Petrova and Joyner,
2014; Wu et al., 2017). To spatially localize choroidal GLI1+ cells,
we used albino Gli1GFP/+ reporter mice in which GFP expression
is controlled by the endogenous Gli1 promoter of one of the al-
leles (Brownell et al., 2011). Thus, HH-responding cells can be
readily identified as GFP+ cells. Immunostaining analysis of
chorioretinal sections from Gli1GFP/+ mice showed that GFP+ cells
were primarily localized surrounding VE-cadherin+ ECs and
colocalized with the stromal marker PDGFRβ (Fig. 3 c). These
results indicate that the main paracrine targets of EC-secreted
IHH are perivascular stromal cells.
Previous work demonstrated the constitutive presence of
perivascular GLI1+ MSC-like cells in several adult mouse tissues.
These cells represent between 0.01% and 0.17% of total tissue
cells and are capable of differentiating into adipocytes, osteo-
blasts, and chondrocytes in vitro (Kramann et al., 2015). To as-
sess their potential similarity with choroidal GLI1+ cells
described here, we first studied the percentage of GFP+ cells in
whole digested tissue by flow cytometry. We found that the
population of resident GFP+ cells in RPE/choroid was 15.8 ± 1.3%,
a much higher percentage compared with lung tissue (1.28 ±
0.2%; Fig. 3 d and Fig. S2). Next, we phenotyped choroidal GFP+
cells by flow cytometry studying the expression of a repertoire
of cell surface markers previously used to characterize GLI1+
MSC-like cells in other tissues (Kramann et al., 2015). We found
that virtually all choroidal GFP+ cells were positive for PDGFRβ
and CD29 and negative for the hematopoietic lineage marker
CD45 and the EC marker CD31, and ∼50% expressed CD105 and
SCA1 (Fig. 3 e). To study whether choroidal GLI1+ cells are plu-
ripotent in vitro, we isolated GLI1+ cells from RPE/choroid of
Gli1GFP/+ mice by cell sorting based on GFP expression. Isolated
GFP+ cells were plastic adherent and could be differentiated into
osteoblast- and adipocyte-like cells (Fig. 3, f and g). Since it is
well established that MSCs inhibit T cell proliferation in vitro
(Uccelli et al., 2008), we tested whether choroidal GLI1+ cells
exert the same effect. Mouse splenocytes were labeled with
CFSE, polyclonally activated, and cultured in the absence or
presence of allogeneic choroidal GLI1+ cells. Proliferation of CD4+
and CD8+ T cells was inhibited in the presence of GLI1+ cells in a
dose-dependent manner (Fig. 3, h–j). Overall, our characteriza-
tion of choroidal GLI1+ cells is in agreement with the MSC-like
identity previously reported for GLI1+ perivascular cells from
other tissues (Kramann et al., 2015).
RPE/choroid transcriptional alterations after EC-specific
deletion of Ihh in adult mice
To directly study the role of choroidal EC-expressed Ihh in
choroidal and retinal homeostasis of adult mice, we generated a
mouse model that enabled EC-specific, inducible Ihh deletion.
Cdh5-PAC-CreERT2 mice, in which a tamoxifen-inducible Cre is
expressed under the control of the EC-specific Cdh5 promoter
(Wang et al., 2010), were crossed withmice harboring floxed Ihh
to obtain Cdh5-PAC-CreERT2 IhhloxP/loxP mice (hereafter termed
IhhiΔEC/iΔEC). To assess Ihh deletion efficiency in our inducible
system, we treated control (Cdh5-PAC-CreERT2 Ihh+/+, hereafter
termed Ihh+/+) and IhhiΔEC/ΔiEC adult mice with tamoxifen and
assessed Ihh mRNA levels in RPE/choroid by real-time PCR. We
observed that IhhiΔEC/iΔEC mice presented a ∼70% reduction in
Ihh mRNA levels. Confirming that IHH signaling is diminished
in mutants, Gli1 expression was similarly decreased (Fig. 4 a).
These results confirmed our scRNAseq data showing that the
main source of Ihh expression in RPE/choroid tissue are cho-
roidal ECs and, importantly, demonstrate that choroidal Gli1
expression depends on EC-expressed Ihh.
Next, we performed bulk RNAseq analyses of RPE/choroid
tissue obtained from tamoxifen-treated Ihh+/+ and IhhiΔEC/iΔEC
mice (Data S1 h). To analyze the impact of EC-specific Ihh de-
letion on the different cell types within RPE/choroid tissue, we
assembled a list of genes whose expression in Ihh+/+ mice was
≥1 FPKM and at least twofold higher than in IhhiΔEC/iΔECmice (adj
P < 0.05). In other words, we selected for genes highly expressed
in RPE/choroid that were markedly down-regulated after EC-
specific Ihh deletion. We then used our scRNAseq analyses of
wild-type mice to plot the relative expression of each of these
genes in all RPE/choroid cell clusters (Fig. 4 b). We found that
relative expression of these genes in RPE was very low. This
result indicated that, at least under basal conditions, EC-specific
Ihh deletion had little impact on RPE transcriptome compared
with the rest of the cell types. Out of the 20 genes included in the
list, we found 8 that were clearly enriched in stromal cell clus-
ters 5–8, including the HH-induced genes Gli1 and Hhip. This
finding was expected, given our previous observation that
stromal cells are the main choroidal Ihh target. Interestingly,
EC-specific Ihh deletion not only altered genes expressed by HH-
responding stromal cells but also down-regulated genes ex-
pressed almost exclusively in other choroidal cell populations
that are not direct targets of IHH. That was the case for Syt4,
Cort, and Sgcg, which are highly enriched in melanocytes,
and Gpr34 and Cma1, which are selectively detected in hemato-
poietic cells. These results strongly suggest that deletion of
Lehmann et al. Journal of Experimental Medicine 6 of 21
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Figure 3. Characterization of choroidal GLI1+ cells. (a) tSNE graphs showing the predominant expression of Ihh and Gli1 in KDRhigh ECs (CC, choriocapillaris)
and stromal cells, respectively. (b) Heatmap showing the relative expression of Ihh, Gli1, and Ptch1 in RPE/choroid cell types, calculated using the average
normalized UMIs in each cluster and represented as the percentage of the cluster with maximum expression. White, 0%; red, 100%. (c) Immunofluorescence
assays using eye cryosections from Gli1GFP/+ mice show the perivascular localization of choroidal GLI1+ cells (GFP+, green). Top: Localization of GFP+ cells and
VE-cadherin+ ECs (purple) is mutually exclusive. Bottom: GFP+ cells colocalize with the stromal marker PDGFRβ (purple). Colocalization in the merged images is
shown in white. Nuclei were stained with Hoechst (blue). Zoomed representative regions of the merged images are shown as insets on the right panels. ONL,
Lehmann et al. Journal of Experimental Medicine 7 of 21
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EC-expressed Ihh indirectly affects choroidal melanocytes and
hematopoietic cells. Finally, a group of genes (Jun, Socs3, Phlda3,
Mcm6, and Arhgap33) presented homogeneous relative expres-
sion inmany choroidal cell types. However, because clusters 5–8
constitute ∼50% of the total cellular content of RPE/choroid
tissue (Table 1), this analysis strategy is not appropriate to elu-
cidate whether the decreased expression of these genes by at
least twofold in the RPE/choroid of IhhiΔEC/iΔECmice results from
their down-regulation in choroidal stromal cells, nonstromal
cells, or both. Taken together, our bioinformatics analyses sug-
gest that EC-expressed Ihh directly regulates gene expression in
GLI1+ perivascular MSC-like cells, which may in turn induce
alterations in other choroidal cell types, including melanocytes
and hematopoietic cells.
Impairment of HH signaling causes loss of choroidal mast cells
Cma1 encodes chymase 1, a protease specifically expressed by
mast cells (Dwyer et al., 2016). Mast cells control innate and
adaptive immune responses and trigger IgE-associated allergic
inflammation (Galli et al., 2008). Although the existence of
choroidal mast cells in humans and rodents is well established
(May, 1999; McMenamin, 1997; McMenamin and Polla, 2013),
their role in the choroid is unknown. The decrease of Cma1 ex-
pression in IhhiΔEC/iΔEC mice (Fig. 4 b) suggested that EC-specific
Ihh expression may control the number and function of cho-
roidal mast cells. We reanalyzed our RNAseq data in search for
other mast cell specific markers (Dwyer et al., 2016) and found
that in addition to Cma1 (adj P = 0.02), Mcpt4 and Tpsb2 ex-
pression was also reduced in IhhiΔEC/iΔECmice more than twofold
(adj P = 0.07 and 0.06, respectively; Data S1 h), albeit not
reaching the statistical significance threshold of adj P < 0.05
used to filter data shown in Fig. 4 b. Real-time PCR assays re-
vealed significantly decreased expression of Cma1, Mcpt4, and
Tpsb2 in RPE/choroid tissue from IhhiΔEC/iΔEC mice (Fig. 4 c),
suggesting that EC-specific Ihh deletion may result in reduced
numbers of choroidal mast cells. To address this possibility, we
performed avidin staining assays to detect mast cells (Tharp
et al., 1985; Veerappan et al., 2008) in RPE/choroid flatmounts.
Because RPE and choroidal pigmentation interferes with flat-
mount imaging, these experiments were performed using albino
mice generated by breeding the C57BL/6J-derived IhhiΔEC/iΔEC
pigmented line with albino mice. Quantitative image analysis
showed reduced numbers of choroidal mast cells in albino mice
after EC-specific Ihh deletion (Fig. 4, d and e). Next, we tested
whether alteration of the HH pathway in GLI1+ cells also resulted
in reduced numbers of choroidal mast cells. We intercrossed
albino Gli1GFP/+ animals to obtain Gli1GFP/GFP mice, which are in-
deed null for Gli1 function. Although Gli1 is dispensable for
normal mouse development (Bai et al., 2002; Park et al., 2000),
Gli1 deletion induces altered phenotypes in particular contexts
(Lees et al., 2008; Merchant et al., 2010). Real-time PCR assays
showed that expression of Cma1, Mcpt4, and Tpsb2 in RPE/cho-
roid tissue from Gli1GFP/GFP mice was significantly reduced
compared with Gli1+/+ mice (Fig. S3 a). Avidin staining assays
showed reduced numbers of choroidal mast cells in Gli1GFP/GFP
mice (Fig. S3, b and c), confirming the importance of HH sig-
naling for choroidal mast cell fate. These results demonstrate
that blunting HH signaling, either by decreasing ligand levels
(IHH) or impairing target cell response (Gli1 deletion), results in
reduced numbers of choroidal mast cells. One attractive expla-
nation for this observation is that mast cell survival in the
choroid may rely on factors provided by HH-stimulated GLI1+
cells. As a proxy to test this hypothesis, we performed in vitro
assays using RBL-2H3 cells, a cell line widely used to study some
features of mast cell physiology (Passante and Frankish, 2009).
Fluorescently labeled RBL-2H3 cells were cultured alone or to-
gether with GLI1+ cells, in the absence or presence of the HH
pathway agonist Smoothened agonist (SAG; Chen et al., 2002).
After 24 h of serum starvation, viability of nonadherent RBL-
2H3 cells was evaluated by DAPI staining. The presence of GLI1+
cells reduced the percentage of dead RBL-2H3 cells (DAPI+),
which was further decreased by the addition of SAG (Fig. 4, f
and g). Importantly, SAG treatment in the absence of GLI1+ cells
had no effect on RBL-2H3 cell viability. In sum, our in vivo and
in vitro assays support a model in which EC-secreted IHH
stimulates choroidal GLI1+ cells to promote mast cell survival.
HH-stimulated GLI1+ cells induce melanocyte proliferation
Because reduced RPE/choroid expression of mast cell markers
correlated well with the actual number of choroidal mast cells,
we reasoned that reduced expression of the melanocyte-
enriched genes Syt4, Cort, and Sgcg in the RPE/choroid of
outer nuclear layer; OS/IS, outer segments/inner segments. Scale bar, 20 µm. Results are representative of at least two independent experiments.
(d) Percentage of GLI1+ cells (GFP+) in RPE/choroid and lung. Left: Representative quantification of choroidal GLI1+ cells from Gli1GFP/+ mice by flow cytometry
(green lines). Gli1+/+mice (black lines) were used as a negative control to set background fluorescence levels. Right: Choroid and lung GLI1+ cells were quantified
by flow cytometry and represented as the percentage of total cells in each tissue (n = 3, t test). ***, P < 0.001. (e) Characterization of choroidal GLI1+ cells by
flow cytometry. Gated GLI1+ cells (GFP+) were analyzed for the expression of CD45 (hematopoietic marker), CD31 (EC marker), and the MSC markers CD105,
CD29, PDGFRβ, and SCA1. Unstained samples (black lines) were used to set background fluorescence levels. Numbers show the percentage ± SD (n = 3) of GFP+
cells positive for the different markers. (f) Choroidal GLI1+ cells were isolated from Gli1GFP/+mice by cell sorting (GFP+ cells) and expanded in culture. GLI1+ cells
were exposed to adipogenic (Ad) or osteogenic (Os) media, and expression of Fabp4 and Spp1 (adipocyte and osteoblast markers, respectively) was assessed by
real-time PCR at days 0 and 21 of differentiation (n = 3, ANOVA + Bonferroni test). ***, P < 0.001. (g) GLI1+ cells were cultured in osteogenic (left) or adipogenic
(right) media for 21 d. Osteogenic and adipogenic differentiation was assessed by the appearance of calcium deposits (Alizarin red S staining) or intracellular
lipid vesicles (oil red O staining), respectively. Day 0 cultures were included as controls. (h) Inhibition of T cell proliferation by GLI1+ cells (experiment outline).
CFSE-labeled allogeneic mouse splenocytes were activated with anti-CD3 antibody and cultured alone or in the presence of choroid GLI1+ cells at different
ratios (GLI1+ cells/splenocytes, 1:1 and 1:4) for 4 d. (i) CFSE dilution histograms showing that the proliferation of CD4+ and CD8+ T cells (white histogram) is
strongly inhibited by choroidal GLI1+ cells at both 1:1 and 1:4 ratios. (j) Quantification of panel i using the division index (average number of divisions after
stimulation) and the percentage of divided cells (No GLI1+ cells, n = 2; 1:1, n = 3; 1:4, n = 3; ANOVA + Bonferroni test). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Results in panels f–j are representative of two independent experiments.
Lehmann et al. Journal of Experimental Medicine 8 of 21











nic) user on 25 M
arch 2020
Figure 4. RPE/choroid transcriptional alterations and loss of choroidal mast cells after EC-specific Ihh deletion. (a) Real-time PCR showing Ihh and Gli1
expression levels in RPE/choroid tissue from Ihh+/+ and IhhiΔEC/iΔECmice (black and blue dots, respectively). Individual dots correspond to different animals, and
red bars represent average values. Relative gene expression is presented as the percentage of Ihh+/+ mice (n = 6, t test). **, P < 0.01. (b) RNAseq analysis of
RPE/choroid tissue from Ihh+/+ and IhhiΔEC/iΔEC mice and cross-comparison with scRNAseq data. The heatmap shows genes with ≥1 FPKM in Ihh+/+ mice that
were significantly down-regulated in IhhiΔEC/iΔEC mice (n = 3, at least twofold change, Benjamini–Hochberg corrected adj P < 0.05). Their relative expression
across RPE/choroid cell types was calculated using the average normalized UMIs in each cluster and represented as the percentage of the cluster with
maximum expression. White, 0%; red, 100%. (c) Real-time PCR showing the expression of mast cell markers in RPE/choroid tissue from Ihh+/+ and IhhiΔEC/iΔEC
mice (n = 3, t test). *, P < 0.05; **, P < 0.01. Results are represented as in panel a. (d) Representative avidin staining assay to localize choroidal mast cells using
flatmounts from albino Ihh+/+ and IhhiΔEC/iΔEC mice. Scale bar, 1,000 µm. (e) Quantification of avidin staining assays shown in panel d. Results are expressed as
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IhhiΔEC/iΔEC mice (Fig. 4 b) may also indicate loss of choroidal
melanocytes. We used our scRNAseq data (Data S1 c) to compile
a complete list of choroidal melanocyte-enriched genes (average
normalized UMIs at least fivefold higher compared with other
cell types; adj P < 0.05) and analyzed their expression in the
RPE/choroid of Ihh+/+ and IhhiΔEC/iΔEC mice as determined by
bulk RNAseq (Data S1 h). We found a trend of reduced expres-
sion in IhhiΔEC/iΔEC mice (65 out of 70 melanocyte-enriched
genes; Data S1 i), and all genes with significant differential ex-
pression (adj P < 0.05) were down-regulated in IhhiΔEC/iΔEC mice
(Fig. S3 d). Conversely, using the same approach, we observed
that Ihh+/+ and IhhiΔEC/iΔEC mice expressed similar levels of all
smooth muscle cell– and choriocapillaris-enriched genes (with
the exception of Ihh for the latter, as expected), suggesting that
the reduction of melanocyte markers was specific (Data S1 i).
These observations indicate that EC-specific Ihh deletion results
in reduced numbers of choroidal melanocytes. To directly test
whether HH signaling modulates melanocyte proliferation, we
performed in vitro experiments using choroidal GLI1+ cells and
the mouse melanocyte cell line melan-a (Bennett et al., 1987).
Conditionedmedia from SAG-stimulated GLI1+ cells, but not SAG
alone, significantly increased the proliferation of serum-starved
melanocytes (Fig. S3 e). These results indicate that, in addition to
promoting mast cell survival, HH-stimulated choroidal GLI1+
cells may modulate the homeostasis of choroidal melanocytes.
HH signaling modulates the expression of
inflammation-related genes in choroidal GLI1+ cells
To gain further insight into the crosstalk mechanisms and
functional roles of the HH pathway in the choroid, we per-
formed RNAseq analyses of cultured choroidal GLI1+ cells in the
absence or presence of the HH pathway agonist SAG (Fig. 5 a and
Data S1 j). Gene Ontology analyses of up- and down-regulated
genes (at least twofold) using DAVID software (Huang et al.,
2009) showed that the most significant transcriptome changes
upon HH pathway activation corresponded to genes related to
immune response, including the categories cellular response to
IFN-β, cellular response to IFN-γ, and innate immune response
(Fig. 5 b). Gene set enrichment analysis (GSEA; Subramanian
et al., 2005) confirmed that SAG treatment significantly re-
duced the expression of genes related to immune response and
cellular response to IFN-β and IFN-γ (Fig. 5 c). Moreover,
Ingenuity Pathway Analysis (Qiagen) showed that HH pathway
activation significantly inhibited transcriptional networks
downstream IFN-β, IFN-γ, several IFN regulatory factors, and
proinflammatory receptors and transcriptional regulators such
as IL-6R, IL-1R1, STAT1, and NF-κB (Data S1 k). Conversely, HH
activation resulted in gene expression changes that mimicked
transcriptional events downstream of IL-10RA, the receptor for
the anti-inflammatory cytokine IL-10 (Data S1 k). Next, we
sought to assess the contribution of such crosstalk mechanism
to the transcriptional changes induced in RPE/choroid tissue
after EC-specific Ihh deletion. Using our RNAseq data, we se-
lected genes whose fold change expression in SAG-treated
GLI1+ cells (adj P < 0.05 versus control cells) was inversely
correlated to the fold change observed in RPE/choroid from
IhhiΔEC/iΔEC mice (adj P < 0.05 versus Ihh+/+ mice; Fig. 5 d). Out
of 158 genes significantly down-regulated in IhhiΔEC/iΔEC mice,
29 were up-regulated in SAG-treated GLI1+ cells. As expected,
these genes included HH downstream targets such as Gli1,
Ptch1, Foxl1, and Hhip. On the other hand, RPE/choroid from
IhhiΔEC/iΔECmice presented increased expression of 181 genes, 15
of which were down-regulated in SAG-treated GLI1+ cells. In-
terestingly, genes with the highest differential expression of
this list included the IFN-activated genes Ifi202b and Gm14446
(Ifit1bl1), as well as F2rl1, which encodes the proinflammatory
receptor PAR2 (Déry et al., 1998; Steinhoff et al., 2000). Col-
lectively, our bioinformatics analyses strongly suggest that HH
signaling blunts the transcriptional changes of choroidal GLI1+
cells in response to proinflammatory factors. Thus, crosstalk
between EC-secreted IHH and stromal GLI1+ cells may be key
for the maintenance of choroidal immune homeostasis.
EC-specific Ihh deletion alters choroidal and retinal
inflammatory responses and aggravates visual function
impairment after tissue damage
To evaluate the impact of EC-specific Ihh deletion on choroid
immune cells, we first sought to identify the different cell types
within choroidal hematopoietic cells and to characterize their
molecular identity.We reanalyzed our scRNAseq data using only
cells from cluster 11 (Fig. 1 b), and unsupervised cell clustering
resulted in five transcriptionally distinct subclusters (Fig. 6 a
and Data S1 l). We assembled lists of specifically enriched
genes (average normalized UMIs at least fivefold higher com-
paredwith other hematopoietic subclusters; adj P < 0.05; Data S1m),
which were used to assess the identity of each subcluster using
the Immunological Genome Project website (Heng et al., 2008;
http://www.immgen.org; Fig. S4 a). Such analysis allowed us to
identify them as macrophages (subcluster H2), T cells (H3),
dendritic cells (DCs; H4), and mast cells (H5). The identity of
subcluster H1 was not obvious, since some H1-specific genes
were found to be expressed in DCs, macrophages, monocytes,
and neutrophils (Fig. S4 a). After close inspection of our
scRNAseq data, we classified H1 as Itgae (CD103)− Itgam
(CD11b)+ classical DCs (cDCs) and H4 as CD103+ CD11b− cDCs
(Merad et al., 2013; Fig. S4 b).
Next, we analyzed how EC-specific Ihh deletion modulates
choroidal immune cells in vivo by combining our scRNAseq
characterization of choroidal cell types and our bulk RNAseq
analyses of RPE/choroid from IhhiΔEC/iΔEC mice. We selected
number of mast cells normalized by flatmount area and presented as relative units (Ihh+/+, n = 3; IhhiΔEC/iΔEC, n = 5, t test). *, P < 0.05. (f) In vitro assays to study
the survival of serum-starved RBL-2H3 cells (red) in the absence or presence of choroidal GLI1+ cells and the HH pathway agonist SAG. Dead cells are DAPI+
(green). (g)Quantification of RBL-2H3 cell death shown in panel f. The graph shows the percentage of DAPI+ RBL-2H3 cells. Black dots correspond to biological
replicates, and red bars represent average values (n = 3, ANOVA + Bonferroni test). Results are representative of two independent experiments. *, P < 0.05; ***,
P < 0.001.
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genes specifically enriched in hematopoietic cells (cluster 11 in
Fig. 1 b; average normalized UMIs at least fivefold higher com-
pared with other cell types; adj P < 0.05; Data S1 c) that were
significantly reduced after Ihh deletion (adj P < 0.05; Data S1 h).
To obtain more hits than those shown in Fig. 4 b (Cma1 and
Gpr34), we did not apply any FPKM or fold-change threshold to
bulk RNAseq data. This analysis revealed that, in addition to
Cma1 and Gpr34, RPE/choroid expression of the hematopoietic-
enriched genes Cd163, Pf4 (CXCL4), Mrc1 (CD206), and Cd72 was
significantly reduced after EC-specific Ihh deletion (Fig. 6 b).
With the exception of Cma1 (specifically expressed in mast cells,
as expected), the rest of hematopoietic-enriched genes that were
down-regulated in RPE/choroid tissue from IhhiΔEC/iΔEC mice
weremarkedly enriched in themacrophage population (Fig. 6 c).
Interestingly, Cd163 and Mrc1 (CD206) are well-established
markers of alternatively activated M2 macrophages, which are
generally involved in inflammation resolution and tissue re-
modeling (Biswas and Mantovani, 2010; Murray, 2017). We
performed immunofluorescence assays and quantitative imaging
analyses onRPE/choroid flatmounts fromalbino Ihh+/+ and IhhiΔEC/iΔEC
mice using antibodies against the murine pan-macrophage
marker F4/80 and the M2 marker CD206. EC-specific Ihh dele-
tion did not alter the percentage of F4/80+ area, suggesting the
presence of a similar number of macrophages than in control
animals (Fig. 6, d and e). However, IhhiΔEC/iΔEC mice showed re-
duced CD206 expression in F4/80+ cells (Fig. 6, d and f). In
summary, our observations suggest that (1) the main choroidal
hematopoietic cell types affected by EC-specific Ihh deletion are
mast cells andmacrophages and (2) EC-specific Ihh deletion skews
macrophage polarization away from the anti-inflammatory M2
phenotype.
In light of these results, we reasoned that inducing RPE/
choroid injury in IhhiΔEC/iΔEC mice might result in a longer or
more pronounced inflammatory response than in control ani-
mals. To test this hypothesis, we performed experiments based
on NaIO3 administration, a well-established model of retinal
injury that induces selective RPE death in a dose-dependent
manner and subsequent photoreceptor loss and vision impair-
ment (Kannan and Hinton, 2014). We injected i.v. a single, low
dose (15 mg kg−1) of NaIO3 into Ihh+/+ and IhhiΔEC/iΔEC mice, and
3 d later, RNA was extracted from RPE/choroid and neural
retina to assess the expression of proinflammatory markers by
Figure 5. HH signaling modulates the ex-
pression of inflammation-related genes in
choroidal GLI1+ cells. (a) Experiment outline.
GLI1+ cells (GFP+) were isolated from RPE/cho-
roid tissue of Gli1GFP/+ mice by FACS. Cultured
cells were exposed to the HH pathway agonist
SAG (100 nM) or vehicle (DMSO) for 24 h, and
gene expression was analyzed by RNAseq.
(b) Biological process (GOTERM_BP_DIRECT)
Gene Ontology analysis of control- and SAG-
treated GLI1+ cells using DAVID software, con-
sidering genes with log2 fold change ≤−1 and
≥1 (n = 3, Benjamini–Hochberg corrected adj P <
0.05). Significantly enriched gene sets are shown
(Benjamini-corrected adj P < 0.05). (c) Pre-
ranked GSEA shows that SAG treatment re-
duces the expression of immune-related genes.
FDR, false discovery rate q-value; NES, normal-
ized enrichment score; Nom. P, nominal P value.
(d) Genes with inversely correlated differential
expression between HH activation in vitro (GLI1+
cells after SAG treatment) and inhibition in vivo
(RPE/choroid tissue after EC-specific Ihh deletion).
Numbers in Venn diagrams indicate the number of
genes significantly up- or down-regulated in each
condition (Benjamini–Hochberg corrected adj P <
0.05). Gray intersections indicate the number of
overlapping genes for each comparison, which are
listed on the graph on the right. Green bars rep-
resent genes up- or down-regulated in SAG-
treated GLI1+ cells compared with control cells,
and red bars represent genes up- or down-regulated
in RPE/choroid tissue from IhhiΔEC/iΔEC mice com-
pared with Ihh+/+ mice.
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real-time PCR.We observed a trend toward increased expression
of all genes tested in both RPE/choroid and neural retina from
IhhiΔEC/iΔECmice, reaching statistical significance for Ccl2 and Tnf
in both tissues and Il6 and Cxcl10 in neural retina (Fig. 6 g). To
test the potential functional consequences of such augmented
proinflammatory profile, we performed optomotor tracking as-
says to assess visual function in Ihh+/+ and IhhiΔEC/iΔEC mice be-
fore and 3 d after NaIO3 administration. In the absence of NaIO3
treatment, EC-specific Ihh deletion did not compromise visual
function (Fig. 6 h). However, NaIO3 treatment induced a
Figure 6. EC-specific Ihh deletion alters choroidal and retinal inflammatory responses and aggravates visual function impairment after tissue
damage. (a) tSNE graph showing five transcriptionally distinct subclusters (H1–H5) within choroidal hematopoietic cells, as determined by scRNAseq.
(b) RNAseq data showing genes significantly enriched in choroidal hematopoietic cells (as determined by our scRNAseq results) and down-regulated in RPE/
choroid from IhhiΔEC/iΔEC mice (blue dots) compared with Ihh+/+ mice (black dots). Individual dots correspond to different animals, and red bars represent
average values. Relative gene expression is presented as the percentage of Ihh+/+ mice (n = 3, Benjamini–Hochberg corrected adj P value). *, P < 0.05; **, P <
0.01; ***, P < 0.001. (c) Relative expression levels of the genes shown in panel b among choroidal hematopoietic subclusters calculated using the average
normalized UMIs in each subcluster and represented as the percentage of the subcluster with maximum expression. White, 0%; red, 100%. (d) Immuno-
fluorescence analysis of F4/80 and CD206 expression in RPE/choroid flatmounts from albino Ihh+/+ and IhhiΔEC/iΔEC mice. Scale bar, 1,000 µm. Panels on the
right show zoomed-in regions (scale bar, 125 µm). (e) Quantification of F4/80+ area shown in panel d. Results are normalized by flatmount area and presented
as relative units (Ihh+/+, n = 3; IhhiΔEC/iΔEC, n = 6, t test). (f) Quantification of CD206 intensity within F4/80+ area shown in panel d. Results are presented as
relative units (Ihh+/+, n = 3; IhhiΔEC/iΔEC, n = 6, t test). *, P < 0.05. (g) Real-time PCR assays showing relative expression levels of pro-inflammatory genes in RPE/
choroid (left) and neural retina (right) from Ihh+/+ and IhhiΔEC/iΔECmice 3 d after i.v. administration of 15mg kg−1 NaIO3. Results are presented as in panel a (n = 4,
t test). *, P < 0.05; **, P < 0.01; ***, P < 0.001. (h) Optomotor response analyses of Ihh+/+ and IhhiΔEC/iΔEC mice before (day 0) and after (day 3) NaIO3 ad-
ministration (day 0, n = 7; day 3, n = 10; ANOVA + Bonferroni test). *, P < 0.05; ***, P < 0.001. c/d, cycles per degree.
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significantly impaired spatial visual function of IhhiΔEC/iΔEC mice
compared with Ihh+/+ mice. These results demonstrate that in a
context of tissue damage, EC-specific Ihh deletion results in an
exacerbated inflammatory response in the RPE/choroid and
neural retina that correlates with a more severe visual function
impairment.
Discussion
Herein, we report the transcriptome of mouse RPE/choroid
tissue at single cell resolution and a study of HH signaling in the
adult choroid. Taken together, our results support a model in
which choroidal EC-expressed Ihh and HH-respondingMSC-like
cells are key for several aspects of choroidal and retinal immune
homeostasis, including survival of choroidal mast cells and in-
flammatory response after tissue damage. Our findings consti-
tute a new angle for the study of inflammation-related ocular
disorders such as AMD.
A main contribution of our work is the identification and
molecular characterization of transcriptionally distinct subtypes
of choroidal ECs. As increasing evidence indicates that micro-
vascular ECs are tissue specific and secrete specialized sets of
angiocrine factors that regulate organ homeostasis and regen-
eration (Rafii et al., 2016), it was intriguing to find that chori-
ocapillaris ECs, located next to RPE cells, exhibit a highly specific
transcriptional profile, including a marked enrichment in Ihh
expression. Previous work in the developing mouse eye has
shown that Ihh is expressed by a subset of choroidal cells adja-
cent to the RPE presumed to be ECs based on the expression of
collagen IV (Dakubo et al., 2003, 2008; Wallace and Raff, 1999).
However, whether Ihh expression is maintained in the adult
choroid remained unknown so far. Our scRNAseq and bulk
RNAseq analyses unambiguously demonstrate that Ihh is ex-
pressed at high levels in adult mouse choriocapillaris ECs rela-
tive to other ECs in the choroid, retina, and extraocular tissues.
The abovementioned study showed that Ihh knockout mice
(which die during embryonic stages or at birth; St-Jacques et al.,
1999) display defects in RPE, sclera, and neural retina prenatal
development (Dakubo et al., 2008); now, we provide evidence
that Ihh expression also plays an important role in adult choroid
homeostasis.
Experiments using reporter Gli1GFP/+ mice revealed that the
main target of choroidal HH signaling is a population of peri-
vascular cells that molecular, cellular, and functional assays
identified as GLI1+ MSC-like stromal cells, in agreement with
previous findings in other organs (Kramann et al., 2015; Zhao
et al., 2014). Importantly, response of these cells to HH signaling
seems to regulate the homeostasis of choroidal mast cells and
melanocytes. It remains to be determined the role of this sig-
naling circuit in the human choroid and its potential disease-
associated alterations; nevertheless, the well-established
immunomodulatory ability of MSCs (Uccelli et al., 2008) and
the involvement of inflammation in several choroid-related eye
pathologies such as AMD, diabetic retinopathy, and uveitis
suggest that the choroid HH pathway we have uncovered may
help in the understanding and treatment of such diseases. In-
terestingly, transcriptional analysis of RPE/choroid tissue from
AMD donors and age-matched controls showed that expression
of the proinflammatory genes CCL2 and CXCL10, which is up-
regulated upon tissue damage after EC-specific Ihh deletion
(Fig. 6 g), is elevated in all major clinical AMD phenotypes
(Newman et al., 2012). The role of HH signaling in the control
and resolution of inflammation has been described in several
pathological contexts, especially in the intestine, at the level of
both HH ligands and target cells. In humans, a GLI1 non-
synonymous polymorphism is strongly associated with ulcera-
tive colitis, where areas of colonic inflammation display
reduced expression of the HH target genes GLI1, PTCH, and
HHIP (Lees et al., 2008). In mice, specific deletion of Ihh from
enteric cells induces the expression of inflammation-related
genes, leukocyte infiltration of the crypt area, and the devel-
opment of intestinal fibrosis (van Dop et al., 2010; Westendorp
et al., 2018). In agreement with our findings in the choroid, the
main target of intestinal HH signaling is a population of
fibroblast-like stromal cells (Westendorp et al., 2018). More-
over, inhibition of intestinal HH signaling by overexpression of
the HH inhibitor HHIP induces spontaneous inflammation, di-
arrhea, weight loss, and death (Zacharias et al., 2010). Using a
mouse model of chemically induced colitis, it was shown that
inhibition or activation of the HH pathway intensifies or
ameliorates colon inflammation, respectively (Lee et al., 2016).
Interestingly, this study showed that HH activation induces Il10
expression by stromal cells and results in increased numbers of
intestinal CD4+FOXP3+ regulatory T cells. Given the connection
between regulatory T cells and mast cells (see below), it would
be interesting to study whether in the intestine, similarly to
our observations in the choroid, HH signaling regulates the
presence of mast cells. Importantly, intestinal mesenchyme
responds to HH signaling in vitro by down-regulating proin-
flammatory genes (Zacharias et al., 2010), in line with our
findings using cultured choroidal GLI1+ cells. Furthermore, the
HH pathway acts as an endogenous anti-inflammatory system
at the level of the blood–brain barrier (Alvarez et al., 2011). We
now add the choroid to the list of adult tissues where the in-
flammatory response is modulated by HH signaling.
Additional in vivo and in vitro experiments indicated that
HH-stimulated MSC-like cells are key for choroidal mast cell
homeostasis and survival. Although mast cells are present in
the choroid of humans and most vertebrates (May, 1999;
McMenamin, 1997; McMenamin and Polla, 2013), their role in
the eye in health and disease remains unknown. AMD is asso-
ciated with an increased number of total and degranulated mast
cells in the choroid (Bhutto et al., 2016; McLeod et al., 2017).
However, the interpretation of these observations is unclear, as
mast cells not only participate in proinflammatory responses but
also can limit inflammation or facilitate its resolution (Caughey,
2011; Galli et al., 2008; Tsai et al., 2011). Mast cells are key for the
immunosuppressive effect of UVB radiation (Hart et al., 1998)
and the induction of tolerance to skin allografts mediated by
CD4+FOXP3+ regulatory T cells (Lu et al., 2006). Interestingly,
genetic mast cell depletion results in increased numbers of in-
filtrating immune cells in the eye after endotoxin-induced
uveitis, suggesting that choroidal mast cells may play a protec-
tive, anti-inflammatory role in this organ (Smith et al., 1998).
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Indeed, our scRNAseq data show that mast cells are the only
choroidal cell type with detectable expression of Il4 (Data S1, b
and m). Given the well-established role of IL-4 in promoting
macrophage polarization toward the anti-inflammatory M2
phenotype (Biswas and Mantovani, 2010; Murray, 2017), it is
possible that mast cell loss contributes to the reduction in M2
markers we observed in choroidal macrophages from IhhiΔEC/iΔEC
mice (Fig. 6, c and d–f). Hence, our results suggest that im-
pairment of HH signaling may impact the pathogenesis of in-
flammatory choroid diseases through a decrease in the population
of choroidal mast cells.
Because RPE and photoreceptor death is a hallmark of AMD,
significant progress has been made to generate stem cell–
derived RPE and photoreceptors for transplantation purposes
(Nazari et al., 2015). However, as choriocapillaris loss is an early
event during the development of AMD (Bhutto and Lutty, 2012;
Whitmore et al., 2015), and because oxygen and nutrient supply
of the outer retina depends on choroidal perfusion, it is likely
that long-lasting engraftment and proper function of trans-
planted retinal cells could be significantly improved by co-
transplantation of choriocapillaris ECs. However, the generation
of such specialized ECs is challenging, in part due to the lack of
information about their molecular identity. To date, only one
laboratory has reported the generation of stem cell–derived
choroid EC-like cells, and the assessment of their resemblance to
authentic choriocapillaris ECs was limited to the expression of a
few markers (Songstad et al., 2015, 2017). Although our char-
acterization of choroidal EC subtypes by scRNAseq needs further
validation in human tissue, it demonstrates marked gene ex-
pression differences between the choriocapillaris and other
choroidal endothelial layers. We believe such transcriptome
heterogeneity should be taken into account when generating
stem cell–derived choriocapillaris ECs suitable for cell replace-
ment strategies. Moreover, cell surface proteins encoded by
choroidal EC signature genes (Fig. 2 c) constitute potential tar-
gets for site-directed delivery of functionalized nanoparticles or
viral vectors after systemic administration, which could open new
therapeutic approaches to treat choroidal and retinal pathologies.
Materials and methods
scRNAseq of mouse RPE/choroid tissue
Experiments were performed with 90-d-old mice of two dif-
ferent strains, C57BL/6J and B6129PF1/J. To isolate viable, single
cells from RPE/choroid tissue, we euthanized the mice and
washed the blood via intracardial perfusion with PBS buffer, and
then enucleated the eyes for further processing. Each eye was
cleaned from extraocular tissue and a circumpherencial incision
was performed right below the ora serrata to remove the ante-
rior segment, including cornea, lens, iris and ciliary body. The
neural retina was detached from the optic nerve and RPE/cho-
roid tissue was gently scraped from the sclera. For each strain,
experiments included one eye from a male and another from a
female, which were mixed as a strategy to estimate the per-
centage of contaminating doublets in our preparation. RPE/
choroid tissue was incubated with Collagenase A (6.25 mg ml−1),
Dispase II (6.25 mg ml−1), and DNase (62.5 µg ml−1; Roche) at
37°C for 15 min as previously described (Benedicto et al., 2017)
and then in 0.25% trypsin-EDTA (Gibco) at 37°C for 5 min to
create a single cell suspension. Both solutions also included
Hoechst (10 µM; Thermo Fisher Scientific) to label nuclei during
digestion. The cell suspension was pelleted, resuspended in
sorting buffer (PBS plus 5% FBS and 2 mM EDTA), filtered
through a 70-µm cell strainer, stained with TO-PRO-3 (1 µg ml−1;
Thermo Fisher Scientific), and purified by FACSwith gates set to
include nucleated particles (Hoechst+) and exclude dead cells
(TO-PRO-3+).
Library preparation, sequencing, and raw data after pro-
cessing were performed at the Weill Cornell Medicine Epi-
genomics Core. scRNAseq libraries were prepared according to
10x Genomics specifications (Single Cell 39 Reagent Kits v2 User
Guide PN-120236; 10x Genomics). Cellular suspensions at a
concentration between 250 and 500 cells/µl were loaded onto
the 10x Genomics Chromium platform to generate barcoded
single-cell gel bead-in-emulsion (GEMs), targeting ∼5,000 sin-
gle cells per sample. GEM-reverse transcription (53°C for
45 min, 85°C for 5 min) was performed in a C1000 Touch
thermal cycler with 96-Deep Well Reaction Module (Bio-Rad).
Next, GEMs were broken and the single-strand cDNA was
cleaned upwith DynaBeadsMyOne Silane Beads (Thermo Fisher
Scientific). The cDNAwas amplified (98°C for 3 min; 98°C for 15 s,
67°C for 20 s; and 72°C for 1 min × 12 cycles) using the C1000
Touch Thermal cycler with 96-Deep Well Reaction Module.
Quality of the cDNA was assessed using an Agilent Bioanalyzer
2100, obtaining a product of ∼1,170 bp. Amplified cDNA was en-
zymatically fragmented, end repaired, A-tailed, subjected to a
double-sided size selection with SPRIselect beads (Beckman
Coulter), and ligated to adaptors provided in the kit. A unique
sample index for each library was introduced through PCR am-
plification using the indexes provided in the kit (98°C for 45 s;
98°C for 20 s, 54°C for 30 s, and 72°C for 20 s × 14 cycles; and 72°C
for 1 min). Indexed libraries were subjected to a second double-
sided size selection, and libraries were then quantified using
Qubit fluorometric quantification (Thermo Fisher Scientific).
The quality was assessed on an Agilent Bioanalyzer 2100, ob-
taining an average library size of 455 bp.
Libraries were diluted to 2 nM and clustered on an Illumina
HiSeq2500 high-output mode at 10 pM on a pair-end read flow
cell and sequenced for 26 cycles on R1 (10x barcode and UMIs),
followed by 8 cycles of I7 Index (sample Index), and 98 bases on
R2 (transcript), with a coverage ∼145 million reads per sample.
Primary processing of sequencing images was done using Illu-
mina’s Real-Time Analysis software. 10x Genomics Cell Ranger
Single Cell Software suite v2.1.0 was used to perform sample
demultiplexing, alignment (mm10), filtering, UMI counting,
single-cell 39 end gene counting, and quality control using the
manufacturer parameters. 3,996 (C57BL/6J mice) and 3,727
(B6129PF1/J mice) single cells were sequenced with ∼34,000
mean reads (∼75% sequencing saturation) and a median of
∼1,500 detected genes per cell.
Unsupervised cell clustering analysis was performed using
the Seurat 2.1 R package (Butler et al., 2018). Cells with <1,700
UMIs, <600 genes, or >10% mitochondrial genes were excluded
from the analysis, as well as genes detected in less than three
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cells. Gene expression raw counts were normalized following a
global-scaling normalization method with a scale factor of
10,000 and a log transformation using the Seurat NormalizeData
function. The top 2,000 highly variable genes from C57BL/6J
and B6129PF1/J datasets were selected, followed by a canonical
correlation analysis (CCA) to identify common sources of vari-
ation between the two datasets and minimize batch effect. The
first 11 aligned CCA results were used to generate two-
dimensional tSNE (RunTSNE in Seurat, perplexity = 30; Van
der Maaten, 2008) and unsupervised cell clustering by a shared
nearest neighbor (FindClusters in Seurat, k.param = 30 and
resolution = 0.8). A list of conserved cell-type–specific genes
were generated by FindConservedMarkers (test.use = “bimod”,
logfc.threshold = 0.5, min.pct = 0.25) function in Seurat, iden-
tifying ≥65 conserved cell-type–specific genes for each cluster in
both mouse strains (adj P < 0.05). Cells contained in cluster 11
(hematopoietic cells) were further subjected to a second round of
unsupervised analysis following the same approach using the
Seurat FindClusters with ∼1.3 resolution. The modified Seurat
function FindAllMarkers was used to identify differentially ex-
pressed genes among subclusters within endothelial and hema-
topoietic cells. P values were calculated using likelihood-ratio
test for single-cell gene expression (McDavid et al., 2013) and
adjusted by the Benjamini–Hochberg method. More detailed
arguments are available on Github (see Code Availability section).
Estimation of doublets was calculated based on the exclusive
expression of Xist and Ddx3y in female and male cells, respec-
tively. Expression of both genes associated to the same cellular
barcode indicates the presence of a doublet. We made the fol-
lowing assumptions: (1) because we pooled the same amount of
tissue from each sex before RPE/choroid digestion, 50% cells are
male and 50% cells are female; (2) female–female and male–male
doublet rates are the same as the female–male doublet rate; and
(3) female–male doublets account for 50% of total doublets, since
the other 50% are female–female and male–male doublets. We
calculated Xist capture rate using the following equations:
Xist+ cells  [(Xist+Ddx3y− cells) + (Xist+Ddx3y+ cells)]
Xist+ capture rate  (Xist+ cells

all cells) × 2.
Note that the capture rate result was multiplied by 2 because
only 50% of all cells are expected to be female. Similar equations
were used to calculate Ddx3y capture rate:
Ddx3y+ cells  [(Xist−Ddx3y+ cells) + (Xist+Ddx3y+ cells)]
Ddx3y+ capture rate  (Ddx3y+cells

all cells) × 2.
Female–male doublet rate was calculated using the following
equation:
(All cells) × (Xist+ capture rate) × (Ddx3y+ capture rate)
× (female −male doublet rate)  Xist+Ddx3y+ cells.
Because female–male doublet rate accounts for 50% of total
doublets, the corrected doublet rate results from multiplying by
2 the female–male doublet rate. Calculations are shown on Fig. S1 b.
Code availability
Custom code has been deposited at GitHub (https://github.com/
nyuhuyang/scRNAseq-MouseEyes).
Immunofluorescence assays and quantitative image analysis
For cryosection staining, mouse eyes were enucleated and
transferred to 4% paraformaldehyde in PBS. A hole was made in
the cornea with a 22G needle, and cornea and lens were re-
moved. Eyecups were incubated in 4% paraformaldehyde for 2 h
at room temperature. Eyes were washed in PBS, incubated in
15% sucrose in PBS for 30 min, and kept overnight at 4°C in 30%
sucrose in PBS. Eyecups were infiltrated in Tissue-Tek optimal
cutting temperature compound (Sakura) and frozen in the same
solution at −80°C. Sections 5–10 µm thick were obtained with a
cryostat (Hacker) and mounted on Superfrost Plus Gold Micro-
scope Slides (Thermo Fisher Scientific). For immunostaining,
eye sections were washed twice for 5 min in PBS, incubated for
1 h at room temperature in blocking buffer (PBS supplemented
with 3% bovine serum albumin and 0.3% Triton X-100; Sigma)
and incubated overnight at 4°C in blocking buffer plus the fol-
lowing primary antibodies: rat anti-mouse KDR (clone Avas12,
1:100, catalog number 136401; BioLegend), mouse anti-claudin 5
(clone 4C3C2, 1:500, catalog number 352588; Invitrogen), mouse
anti-RPE65 (clone 401.8B11.3D9, 1:100, catalog number NB100-
355; Novus Biologicals), rat anti-mouse CD140b (PDGFRβ; 1:200,
catalog number 14–1402-81; Invitrogen), and/or rabbit anti-GFP
(1:1,000, catalog number A11122; Invitrogen). After three washes
in PBS for 10 min each, sections were incubated for 1 h at room
temperature with Alexa Fluor 647 goat anti-rat and/or Alexa
Fluor 488 goat anti-rabbit or anti-mouse antibodies (1:500; Life
Technologies) in blocking buffer, washed three times in PBS for
10 min each, and mounted with Vectashield (Vector Laborato-
ries). Intravital labeling of ECs was performed by retroorbital
i.v. delivery of 20 µg Alexa Fluor 647–conjugated rat anti-mouse
VE-cadherin (clone BV13, catalog number 138006; BioLegend) in
mice previously anesthetized using isoflurane. After 10 min,
mice were perfused with 4% paraformaldehyde and euthanized,
and eyeballs were enucleated and processed for immunofluo-
rescence as described above. To stain mast cells and macro-
phages in RPE/choroid flatmounts from albino mice, animals
were dark-adapted overnight for better detachment of retina
from the RPE and euthanized the following day. Eyes were
enucleated and fixed in 4% paraformaldehyde in PBS for 2 h at
room temperature, and cornea and lens were removed during
fixation. Eyecups were washed twice in PBS and retina was
carefully removed. RPE/choroid tissue was processed and
stained as described above using Rhodamine Avidin D, TMRITC
(1:250, catalog number A-2002; Vector Laboratories) for mast
cell detection (Tharp et al., 1985; Veerappan et al., 2008), or rat
anti-mouse F4/80 (1:500, catalog number ab6640; Abcam) and
rabbit anti-mouse CD206 (1:500, catalog number ab64693; Ab-
cam) plus Alexa Fluor 647 goat anti-rat and Alexa Fluor 568 goat
anti-rabbit for macrophage staining. Images were collected with
a Zeiss Axio Observer spinning disk confocal microscope
equipped with a Yokogawa scanner unit, Hamamatsu Evolve
electron-multiplying charge-coupled device cameras (Photo-
metrics), and either a 63× (Fig. 3 c) or 20× (for flatmounts) ob-
jective. Images from Fig. 1 e were acquired using a Zeiss Axio
Observer LSM 880 confocal microscope with a Plan Apochromat
40×/numerical aperture 0.95 objective. Mast cell quantification
was performed using the open-source software Ilastik, which
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implements a random forest supervised machine learning clas-
sifier (Berg et al., 2019). Briefly, an initial training was per-
formed using a control flatmount to separate foreground objects
(mast cells) from the background and then applied to the re-
maining samples. The segmented binary images were exported
and further processed in ImageJ using fill holes and watershed
functions and then quantified using the analyze particles func-
tion. Mast cell numbers were normalized to the total area for
each flatmount. Macrophage quantification was performed with
ImageJ software. After background subtraction (20 pixels), F4/
80 signal was thresholded (default parameters) and used to
create a selection, which was normalized by total flatmount area
to calculate F4/80+ area. The same F4/80+ selection was applied
to the background-subtracted CD206 image. CD206 mean in-
tensity was measured within the F4/80+ selected area without
applying any threshold.
Isolation and RNAseq of tissue-specific mouse ECs
Mouse tissue-specific ECs were isolated from 30-d-old
B6129PF1/J mice by intravital staining of VE-cadherin followed
by tissue digestion and cell sorting as previously described
(Benedicto et al., 2017). Cells were lysed immediately after
sorting and processed for RNAseq as previously described
(Benedicto et al., 2017). RNAseq was performed from three in-
dependent isolations, with 7 animals (14 eyes) per isolation for
RPE/choroid and neural retina, and one mouse per isolation for
liver, lung, and heart. cDNA libraries were prepared with the
TruSeq RNA Sample Preparation Kit (Illumina) and sequenced
on an Illumina HiSeq2000 platform. Upon quality control using
FastQC, raw reads were aligned to the mouse genome (mm10),
downloaded via the UCSC genome browser (http://hgdownload-
test.cse.ucsc.edu/goldenPath/mm10/bigZips/) using STAR_2.4.
0f1 (Dobin et al., 2013) and SAMTOOLS v0.1.19 (Li et al., 2009)
for sorting and indexing reads. Cufflinks (2.0.2; Trapnell et al.,
2012) was used to get the expression values (FPKM). Log-
transformed FPKM profiles were clustered using hierarchical
clustering (hclust function in R language) with average linkage
and one minus Spearman correlation as distance. To determine
the genes differentially expressed between choroidal ECs and
ECs from neural retina, lung, liver, and heart, statistical signif-
icance was calculated using DEseq2 bioconductor package in R,
which uses read counts (htseq-count; Love et al., 2014). With a
detection threshold set at ≥1 FPKM, genes expressed in choroidal
ECs at levels at least fivefold higher compared with ECs from
neural retina, lung, liver, and heart (Benjamini–Hochberg cor-
rected adj P < 0.05) were considered choroidal EC signature genes.
Gene expression analyses of mouse ECs and RPE/choroid
tissue by real-time PCR
For tissue-specific native ECs, RNA was extracted immediately
after sorting using TRI Reagent (Molecular Research Center) and
the RNeasyMini Kit (Qiagen) as previously described (Benedicto
et al., 2017). For mouse RPE/choroid tissue, mice were eutha-
nized, and eye globes were enucleated followed by careful ex-
cision of any extraocular tissue that remained attached to the
sclera. The anterior segment was discarded, and after removal
of the neural retina, RPE/choroid tissue was mechanically
dissected from the sclera using a scalpel and immediately used
for RNA extraction with the RNeasy Mini Kit (Qiagen). cDNA
was prepared with the High Capacity cDNA Reverse Transcrip-
tion Kit (Life Technologies), and real-time PCRwas performed in
a StepOnePlus Real-Time PCR System (Life Technologies) using
SYBR Select Master Mix (Life Technologies) and the following
mouse primer pairs: Ihh (NM_010544, 59-ACGTGCATTGCTCTG
TCAAG-39 and 59-GTCTCCTGGCTTTACAGCTG-39),Gli1 (NM_010
296, 59-CCCAGCTCGCTCCGCAAACA-39 and 59-CTGCTGCGGCAT
GGCACTCT-39), Cma1 (NM_010780, 59-CAAGCCTGCAAACACTT
CAC-39 and 59-CATAGGATGCAATGCCTTGG-39), Mcpt4 (NM_01
0779, 59-ATCTGGAGATCACCACTGAG-39 and 59-TCACATCATGA
GCTCCAAGG-39), Tpsb2 (NM_010781, 59-CCATTGTCCATGATGG
CATG-39 and 59-TGTAGATGCCAGGCTTGTTG-39), Fabp4 (NM_0
24406, 59-GTGATGCCTTTGTGGGAACC-3 and 59-TCATGTTGGG
CTTGGCCATG-39), Spp1 (NM_001204233, 59-TGCCTGACCCATC
TCAGAAG-3 and 59-TCGTCGTCCATGTGGTCATG-39), Il6 (NM_
031168, 59-GAACAACGATGATGCACTTGC-39 and 59-TCCAGGTA
GCTATGGTACTC-39), Ccl2 (NM_011333, 59-CATTCACCAGCAAGA
TGATCC-3 and 59-TGTATGTCTGGACCCATTCC-39), Nos2 (NM_0
01313921, 59-TGCCTCATGCCATTGAGTTC-3 and 59-AGATGAGCT
CATCCAGAGTG-39), Tnf (NM_013693, 59-CTCTTCTCATTCCTG
CTTGTG-3 and 59-TCTGGGCCATAGAACTGATG-39), and Cxcl10
(NM_021274, 59-AGTGAGAATGAGGGCCATAG-3 and 59-TCCGG
ATTCAGACATCTCTG-39). Gapdh (NM_008084, 59-AAATGGTGA
AGGTCGGTGTG-39 and 59-GAGTGGAGTCATACTGGAAC-39) was
used as loading control, and relative expression values were
calculated by the 2−ΔΔCt method.
Assessment of IHH expression in human tissues
Human retina and combined RPE/choroid punches were se-
lected from a research collection at the University of Iowa In-
stitute for Vision Research. This collection contains tissues
obtained from the Iowa Lions Eye Bank (Iowa City, IA) after full
consent of the donors’ families. All experiments conformed to
the Declaration of Helsinki. The eyes used in this study had no
known ocular history of AMD. Eyes were dissected by making a
circumferential incision behind the limbus and removing the
anterior segment consisting of cornea, iris, lens, and ciliary
body. The remaining posterior pole was cut into a clover-leaf
shape by making four equally spaced incisions through the
sclera, choroid, RPE, and retina. An 8-mm sterile disposable
trephine punch, centered on the fovea centralis, was collected
from the macular region (easily identified by the presence of
foveal pigment, proximity to the optic nerve head, and location
between the superior and inferior arcades in the temporal ret-
ina). Neural retina and RPE/choroid samples were flash frozen
separately in liquid nitrogen, and all procedures were completed
within 5.5 h after death. Punches were stored at −80°C until
used for RNA isolation. Samples were removed from the −80°C
freezer and placed immediately on dry ice, such that they
thawed in the presence of RNA extraction buffer (as even brief
thawing is extremely destructive to RNA yield). Total RNA from
RPE/choroid and neural retina was extracted using the RNeasy
Mini Kit (Qiagen). Alternatively, total RNA from human lung,
liver, and heart was obtained from Takara. Reverse transcrip-
tion was performed in a 50-µl reaction using a reverse
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transcription kit (MultiScribe; Thermo Fisher Scientific). IHH
expression was determined by real-time PCR (NM_002181, 59-
ATGACCCAGCGCTGCAAG-39 and 59-CAAAGCCGGCCTCCACTG-39)
as described previously (Zeng et al., 2012) using RPL19 expression
for normalization (NM_000981, 59-ATGCCAACTCCCGTCAGC-39
and 59-ACCCTTCCGCTTACCTATGC-39) and calculating relative
expression values by the 2−ΔΔCt method. All samples were ana-
lyzed in technical triplicates.
Characterization of GLI1+ cells by flow cytometry
Gli1GFP/+ reporter mice in which GFP expression is controlled
by the endogenous Gli1 promoter are described elsewhere
(Brownell et al., 2011). Because these animals were generated in
the Swiss strain (SWR/J), they present retinal degeneration due
to the homozygous rd1mutation in the Pde6b gene (Chang et al.,
2002). To avoid having confounding results due to retinal de-
generation, we outcrossed these animals with wild-type BALB/c
mice and intercrossed the offspring for at least two generations
to remove the rd1 phenotype before further characterization.
RPE/choroid tissue from Gli1GFP/+ mice was mechanically dis-
sected from the sclera as described above and digested in colla-
genase A, dispase II and DNase as previously reported (Benedicto
et al., 2017). Lungswere digested in the same conditions and used
to compare the percentage of GFP+ cells. For staining, cells from
two eyes were pelleted at 400 g for 5 min and resuspended in
FACS buffer (PBS, 5% FBS, and 2 mM EDTA) including a CD16/
CD32 antibody to block Fc receptors (clone 93, 1:200, catalog
number 101302, BioLegend). Cells were filtered through a 40-µm
cell strainer and incubated for 30 min at room temperature with
the following fluorochrome-conjugated antibodies (BioLegend):
CD45-APC/Cy7 (1:200, catalog number 103115), CD31-BV605 (1:
200, catalog number 102427), CD29-PE/Cy7 (1:800, catalog
number 102221), CD105-PerCP/Cy5.5 (1:800, catalog number
120415), PDGFRβ-PE (1:200, catalog number 136005), and SCA1-
BV711 (1:200, catalog number 108131). Cells were washed three
times in FACS buffer and resuspended in FACS buffer with 1 µg/
ml DAPI to stain dead cells and exclude them from the analysis.
Compensation controls were prepared using antibody-stained
UltraComp eBeads (Thermo Fisher Scientific). Cells and beads
were analyzed using a BD Fortessa flow cytometer and results
were analyzed with FlowJo software.
Generation of EC-specific Ihh knockout mice
Generation of EC-specific Ihh inducible knockout was achieved
by breeding IhhloxP/loxP mice (Jackson Laboratories) with Cdh5-
CreERT2 transgenic mice (Wang et al., 2010) to establish the
Cdh5-CreERT2 IhhloxP/loxP line (IhhiΔEC/iΔEC). To induce Cre activity,
animals were i.p. treatedwith tamoxifen at a dose of 250mg kg−1
in sunflower oil for 6 d (interrupted for 3 d after the third dose).
After 8–12 wk of tamoxifen treatment, RPE/choroid tissue was
processed for RNAseq, real-time PCR, or imaging assays. Albino
Ihh+/+ and IhhiΔEC/iΔEC were generated by crossing pigmented
IhhiΔEC/iΔEC mice with albino Gli1+/+ mice already free of rd1
mutation (see above). Heterozygous agouti (brown color) Ihh+/iΔEC
mice were obtained and crossed to generate albino homozygous
IhhiΔEC/iΔEC mice. Second-generation animals were used for either
experiments or further breeding. In all experiments, tamoxifen-
injected littermate Cdh5-CreERT2 Ihh+/+mice were used as controls,
and both male and female animals were used.
Culture, differentiation, and RNAseq analysis of choroidal
GLI1+ cells
Sorting experiments to isolate Gli1+ cells were performed at the
Weill Cornell Medicine Flow Cytometry Core. RPE/choroid tis-
sue from six Gli1GFP/+ mice (female, 72 d old) was dissected and
digested in collagenase A, dispase II, and DNase as described
above. GFP+ live cells (DAPI−) were isolated with a BD Influx cell
sorter into a well of a p24 plate containing 1 ml GLI1+ medium
containing MEM α modification (Sigma) plus penicillin/strep-
tomycin 50× solution (Corning), Glutamax 100× solution, and
20% FBS (Life Technologies). Cells were expanded up to three
passages and frozen until further use.
For differentiation experiments, cells were cultured in
StemXVivo Osteogenic/Adipogenic Base Media supplemented
with either 100× adipogenic or 20× osteogenic supplement (R&D
Systems) following themanufacturer’s instructions. After 21 d of
differentiation, cells were processed for real-time PCR to assess
the expression of adipogenic (Fabp4) and osteogenic (Spp1)
markers (see above). Adipogenesis and osteogenesis were also
monitored by staining with Oil Red O and Alizarin Red S
(Sigma), respectively. At day 21, cells were washed in PBS and
fixed in 4% paraformaldehyde for 30 min at room temperature.
For adipogenesis assays, cells were incubated in 60% isopropa-
nol for 5 min at room temperature, followed by a 15 min incu-
bation in a filtered 3:2 dilution of Oil Red O stock solution (0.3%
in isopropanol) and water. Cells were then washed with distilled
water and imaged with an inverted microscope (Zeiss Axio
Observer). For osteogenesis experiments, fixed cells were stained
with 2% Alizarin Red S in water (pH 4.2) for 45 min at room
temperature, extensively washed with water and photographed.
For RNAseq experiments, cultured GLI1+ cells were starved
overnight in 0.5% FBS−containing GLI1+ medium, followed by
stimulation with 100 nM SAG (Cayman) or vehicle (DMSO).
After a 24-h incubation, RNA from three biological replicates
was extracted with the RNeasy Mini Kit (Qiagen) after direct
lysis of cells in the culture plate and processed for RNAseq. Bi-
oinformatics analyses were performed as described above. With
a detection threshold set at ≥1 average FPKM in the condition with
most abundant expression, genes whose expression changed at
least twofold after SAG treatment (Benjamini–Hochberg corrected
adj P < 0.05) were selected to carry out Gene Ontology analyses
with DAVID software (Huang et al., 2009). Ingenuity Pathway
Analysis (Qiagen) was performed with the same gene set but
without FPKM or fold-change threshold. GSEAs (Subramanian
et al., 2005) using the terms “immune response” (GO: 0006955),
“cellular response to interferon-β” (GO: 0035458), and “cellular
response to interferon-gamma” (GO: 0071346) were performed to
compare the transcriptomes of control and SAG-treated cells.
Mast cell survival assay
Confluent GLI1+ cells grown in 48-well plates were starved in
0.5% FBS-containing GLI1+ medium for 16 h, followed by stim-
ulation with 100 nM SAG (Cayman) or vehicle (DMSO) for 24 h.
As controls, we included DMSO- and SAG-containing wells
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without cells. RBL-2H3 cells (CRL-2256; ATCC) were labeled
with CellTracker Red CMTPX dye (C34552; Thermo Fisher Sci-
entific) according to the manufacturer’s instructions, and
25,000 cells/well were added on top of control or SAG-
stimulated GLI1+ cells and on wells without GLI1+ cells, in the
absence or presence of SAG. After 24 h, cultures were stained
with DAPI (1:2,000, catalog number D21490; Invitrogen) for
2 min, and nonadherent cells were transferred to a new 48-well
plate and centrifuged at 400 g for 5 min. Cells were fixed with
2% paraformaldehyde in PBS and images were obtained using an
LSM510 confocal microscope using Zen software (Zeiss) in three
1,270 × 1,270 µm fields per well. Cell death was calculated as the
percentage of CellTracker Red CMTPX dye–positive cells that
were labeled with DAPI, using National Institutes of Health
ImageJ software (version 1.49).
Melanocyte proliferation assay in conditioned media from
choroidal GLI1+ cells
To prepare conditioned media, GLI1+ cells were starved in 0.5%
FBS-containing GLI1+ medium for 16 h, followed by stimulation
with 100 nM SAG or vehicle (DMSO) for 48 h. As controls, we
included DMSO- and SAG-containing wells without cells. Media
was collected, cleared by centrifugation and used immediately.
Melan-a cells were cultured in RPMI media as previously de-
scribed (Bennett et al., 1987) and seeded in triplicate (2,500
cells/well) on black, clear-bottom 96-well plates in 100 µl cul-
ture media. After 24 h, cells were starved for further 24 h in
0.5% FBS-containing GLI1+ medium. Media was replaced with
GLI1+ conditioned media prepared as described above. In par-
allel, we included melan-a cells seeded at the same density and
grown in normal melan-a culture media that were representa-
tive of maximum growth. Cell number was measured 48 h after
media change using the CyQUANT Direct Cell Proliferation As-
say Kit (catalog number C35012; Thermo Fisher Scientific) and
measuring fluorescence (480/535 nm excitation/emission) with
a SpectraMax M2 Multi-Mode Microplane Reader (Molecular
Devices). After background subtraction, relative cell number
was calculated as the percentage of fluorescence intensity of
melan-a cells cultured in their regular medium.
T cell proliferation assays
The intracellular fluorescent dye CFSE (Invitrogen) was used to
determine cell division in responder cells as previously de-
scribed (Lyons et al., 2013). Briefly, splenocytes were obtained
from BALB/c mice and washed using a 5-ml syringe to prepare a
single-cell suspension. Red blood cells were lysed with ammo-
nium chloride lysing buffer (0.15 M NHCl, 1 mM KHCO, and
0.1 mM EDTA) for 5 min at room temperature. Splenocytes were
labeled with 1 µM CFSE in PBS for 7 min at 37°C. The reaction
was stopped with ice-cold PBS supplemented with 10% FBS and
washed twice. Labeled cells were cultured either alone or in co-
culture at different ratios with GLI1+ cells in the presence of 1 µg
ml−1 anti-CD3 monoclonal antibody (catalog number BE0001-1;
Bio X Cell), which served as a cell activator. After 4 d of culture,
responder nonadherent cells were harvested, stained with 0.5
µg ml−1 PerCP- and PE-labeled anti-CD4 and anti-CD8a anti-
bodies, respectively (catalog numbers 553052 and 553033; BD
PharMingen) and analyzed by flow cytometry (BD FACS CANTO
II). CD4+ and CD8+ T cells were selected through gating and
analyzed for CFSE fluorescence intensity. Data analysis was
performed using FlowJo software (version 8; TreeStar) to obtain
the division index (average number of cell divisions that a cell in
the original population has undergone) and the percentage of
cells from the original sample that divided.
NaIO3 treatment and optomotor response assays
Visual thresholds of Ihh+/+ and IhhiΔEC/iΔEC mice were measured
by evaluating optokinetic tracking in a virtual optokinetic sys-
tem as described previously (Benedicto et al., 2017). After
measuring baseline visual function, Ihh+/+ and IhhiΔEC/iΔEC mice
were anesthetized and injected i.v. with a single dose of 15 mg
kg−1 NaIO3 (Sigma) using a 30G needle. After 3 d, optomotor
response assays were performed and mice were euthanized.
Eyes were processed for RNA extraction from RPE/choroid and
neural retina, and relative gene expression was assessed by real-
time PCR (see above).
Statistical analyses
All graphs show individual data points and their average. The
number of biological replicates (n) is indicated in each figure
legend. Statistical significance was calculated using unpaired
two-tailed t test or one-way ANOVA plus Bonferroni post hoc
analysis (*, P < 0.05; **, P < 0.01; and ***, P < 0.001) as indicated.
No statistical methodwas used to predetermine sample size or to
test for normality and variance homogeneity. Data points >1.5
interquartile ranges below the first quartile or above the third
quartile were considered outliers and excluded from the anal-
yses. All in vivo experiments were blinded and included litter-
mate controls.
Ethical compliance
All animal protocols were reviewed and approved by the Insti-
tutional Animal Care and Use Committee at Weill Cornell
Medicine.
Data availability
All data supporting the findings of this study are available
within the article and its supplemental information files or upon
request. Bulk RNAseq data from mouse choroid ECs (Benedicto
et al., 2017) were previously deposited in the Gene Expression
Omnibus under series number GSE95835. RPE/choroid scRNA-
seq and bulk RNAseq data (tissue-specific ECs, RPE/choroid
from Ihh+/+ and IhhiΔEC/iΔECmice, and cultured GLI1+ cells ± SAG)
have been deposited in the Gene Expression Omnibus under
series number GSE135167.
Online supplemental material
Fig. S1 shows data regarding scRNAseq analyses, including the
cell-sorting approach used to generate RPE/choroid single-cell
suspensions, superimposed tSNE plots from C57BL/6J and
B6129PF1/J mouse strains, calculations for doublet estimation,
and cluster-specific gene expression for C57BL/6J mice. Fig. S2
shows the gating strategy used to analyze GLI1+ cells by flow
cytometry. Fig. S3 shows loss of mast cells in Gli1-null mice,
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down-regulation of melanocyte markers in RPE/choroid tissue
after EC-specific Ihh deletion, and increased melanocyte prolif-
eration in vitro in the presence of conditioned media from
SAG-stimulated GLI1+ cells. Fig. S4 shows the bioinformatics
characterization of choroidal hematopoietic cells. Data S1
shows complete datasets derived from scRNAseq and bulk
RNAseq analyses.
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Figure S1. scRNAseq of RPE/choroid tissue. (a) Cell sorting to prepare RPE/choroid single-cell suspensions suitable for scRNAseq. Experiments were
performed with the strains C57BL/6J (top panels) and B6129PF1/J (bottom panels). For each strain, RPE/choroid tissue from one male and one female eye was
pooled, digested, and stained with Hoechst and TO-PRO-3 to label nucleated and dead cells, respectively. Unstained samples were used as controls to set the
gating parameters. Pilot experiments showed two different Hoechst+/TO-PRO-3− populations with dim (blue dots) and high (red dots) Hoechst staining.
Hoechstdim events presented very low forward scatter (FSC; right panels), suggesting that this population could be debris. To assess the cellular content of both
populations, we sorted Hoechstdim/TO-PRO-3− and Hoechsthigh/TO-PRO-3− events independently and observed them under the microscope. The Hoechstdim
population contained cell debris (dashed yellow squares) but also many cells that were mainly pigmented (black arrows). Hence, our results suggest that cell
pigment present in RPE and melanocytes may decrease the apparent FSC of both cell types. The Hoechsthigh population (red) was virtually free of debris and
mainly constituted by nonpigmented cells (white arrows). To avoid loss of pigmented cells, both Hoechstdim/TO-PRO-3− and Hoechsthigh/TO-PRO-3− pop-
ulations were sorted together in the same collecting tube and used for scRNAseq assays. Scale bar, 50 µm. (b) Estimation of doublet content in scRNAseq
assays (see calculations in Materials and methods). (c) Principal-component analysis of 7,723 single-cell expression profiles obtained from a mix of male (n =
1 per strain) and female (n = 1 per strain) RPE/choroid tissue. Data are shown in two dimensions using tSNE after CCA batch correction. Black dots, 3,996 cells
from C57BL/6J mice; red dots, 3,727 cells from B6129PF1/J mice. (d) Identification of cell types in RPE/choroid tissue from C57BL/6J mice according to the
average expression of known markers in each cluster. Cluster number colors are the same as in Fig. 1 (b and c). Relative gene expression among cell types was
calculated using the average normalized UMIs in each cluster and represented as the percentage of the cluster with maximum expression. White, 0%;
red, 100%.
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Figure S2. Gating strategy to quantify and characterize GLI1+ cells from Gli1GFP/+ mice by flow cytometry. (a and b) Analysis of GFP+ cells from RPE/
choroid (a) and lung (b). Tissue from Gli1+/+ mice was used as negative control. FSC-H, forward scatter height; SSC-A, side scatter area; SSC-H, side scatter
height; SSC-W, side scatter width.
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Figure S3. Effects of HH signaling on choroidal mast cells and melanocyte proliferation. (a) Real-time PCR showing the expression of mast cell markers
in RPE/choroid tissue from Gli1+/+ and Gli1GFP/GFP mice (black and green dots, respectively). Individual dots correspond to different animals, and red bars
represent average values. Relative gene expression is presented as the percentage of Gli1+/+ mice (n = 4, t test). *, P < 0.05; **, P < 0.01. (b) Representative
avidin staining assay to localize choroidal mast cells using flatmounts from albino Gli1+/+ and Gli1GFP/GFPmice. Panels show binary images used for segmentation,
and dashed lines delineate flatmount contours. Scale bar, 500 µm. (c) Quantification of avidin staining assays shown in panel b. Results are expressed as
number of mast cells normalized by flatmount area and presented as relative units (Gli1+/+, n = 3; Gli1GFP/GFP, n = 4; t test). **, P < 0.01. (d) Differential ex-
pression of melanocyte-enriched genes in RPE/choroid from Ihh+/+ and IhhiΔEC/iΔEC mice as determined by bulk RNAseq (n = 3, Benjamini–Hochberg corrected
adj P < 0.05). (e) Serum-starved melan-a cells were grown in culture medium alone, culture medium supplemented with 100 nM SAG, or conditioned media
(CM) from unstimulated or 100 nM SAG–treated GLI1+ cells. All conditions included 0.5% FBS. After 48 h, cell number was assessed and represented as the
percentage of cells grown in normal melan-a culture medium with 10% FBS. Individual dots correspond to three independent experiments performed in
biological triplicates, and red bars represent average values (n = 3, ANOVA + Bonferroni test). *, P < 0.05.
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Figure S4. Classification of choroidal hematopoietic cell subclusters. (a) Gene lists from Data S1 m were analyzed at the Immunological Genome Project
website (http://www.immgen.org) using My GeneSet function (V1 datasets for subclusters H1-4, V2 datasets for subcluster H5). (b) Expression of CD103−
CD11b+ and CD103+ CD11b− cDC markers (based on Merad et al., 2013) by H1 and H4 subclusters. Average normalized UMIs for each gene and subcluster were
extracted from Data S1 l.
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A supplemental dataset is available online that provides information regarding all scRNAseq and bulk RNAseq differential
expression analyses used in the study.
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